TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antiretroviral medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Percent Change in Fasting LDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in bacteria rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in primary allergic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receptor Occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic value of ferritin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Global and Regional longitudinal systolic strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood concentrations of SAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma concentrations of GSK2315698
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: chronic postmastectomy pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ITBLs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Who Quit Smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nasal obstruction symptom scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Sitting DBP Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Infant acceptance of medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to pleurodesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum-tolerated dose of mibefradil dihydrochloride
Endpoint domain: Adverse events/effects
Primary endpoint: Minimum Distance of Esophageal Deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Periprocedural complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Stroke
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in writing amplitude (cm) on tablet after 6 weeks of training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in brain activity during writing (functional MRI) after 6 weeks of training
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depressive symptoms measured by Quick Inventory of Depressive Symptomatology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with elevated CK-MB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fat layer thickness changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Numerical pain rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy dysregulation in the whole brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy dysregulation in the motor-sensory region (MSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurodegeneration in the MSR after 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success following root sealing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptomatic onset of monogenic stone disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for HAT diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for HAT diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants participating in study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Geometric Mean Change in HIV-1 Viral Load (VL) From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Subjects With Abnormal Haematological and Biochemical Values
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained Ventricular Fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebrospinal fluid fatty acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: concentration of serum 1,25 dihydroxy vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: concentration of serum calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of driver gene abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Oxytocin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Chlamydia-specific cellular responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Preferred and fast gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed union or nonunion of the distal femur
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Reduction in Office Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction Survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Anxiety Survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Need for Intubation and Mechanical Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in Brachial artery flow mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in participant's motor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in the cognitive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy of azivudine tablets combined with reverse transcriptase inhibitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of UIP vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Absolute change in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Curve From 0 to 12 Hours (AUC12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough Concentration (C12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of mortalities and severe morbidities
Endpoint domain: Adverse events/effects
Primary endpoint: Humoral Response to Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain Reported on the Visual Analogue Scale (VAS) at 30 Minutes Postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Reported on the Visual Analogue Scale (VAS) at 60 Minutes Postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Atopic Dermatitis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with Surgical Site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Antibody Titer ≥ 10 1/Dil Against Each Dengue Virus Serotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With Solicited Injection-site and Systemic Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Self-reported enrollment into school
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Self-report missed days in school in the past 30 days
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Results from HIV rapid test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Safety profile of repeated doses of ITF2984
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics (PK) profile of multiple ascending doses of ITF2984
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in lipoprotein profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in amounts of liver fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in HDL-efflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone volume / tissue volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With 20+% Cerebral Desaturation Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: % of Residents Who Pass the UCC at the T2 Assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in Perioral Lines Severity Scale (POLSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of corneal melting post-Kpro
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: SNOT-22 survey scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Anterior Skull Base QOL survey scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Recover (QOR 40) survey scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serum aminotransferases (ALT, AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral state index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Log-Transformed Testicular Volume (TV) to Week 64
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Propofol Usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Veteran's RAND 12 (VR-12) Mental Composite Score (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: Veteran's RAND 12 (VR-12) Physical Composite Score (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Microvascular perfusion indices (IMR and CFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum-based proteomic biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilatory ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mini State Trait Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Distance between endotracheal tube tip and carina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: annual failure rate of class IV modified ART restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycaemic index values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Food intake over 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in NREM time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ENG test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VEMP test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vHIT test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inflammatory markers expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients with successful ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Continuous Glucose Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Glucose Regulatory Hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall Response Rate in the CNS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence of experimental capsule formulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change across the cardiac circulation of oleate and the glucose/lactate ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of Oxygenation Support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in left ventricle systolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of adverse reactions related to the ketogenic treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in the Physical Component Summary of the SF-12 Health Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in the Mental Component Summary of the SF-12 Health Survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analogue Scale (VAS) Score for Pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Mean Cortical Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy of Soberlink Cellular Device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: buccal bone width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter Colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Control of bleeding at donor graft site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Severity of adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Time of occurrence of adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Type of adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Average postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of Diabetes Mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Subjects With an Investigator Assessment of Clinical Outcome (Success/Failure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects With an Investigator Assessment of Clinical Outcome (Cure/Improvement/Failure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity and mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Chronic graft-versus-host disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Self Care Agency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to PrEP using plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to PrEP using dried blood spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Pain Severity-Graded Chronic Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Reoperations
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) by Severity
Endpoint domain: Adverse events/effects
Primary endpoint: 24hr fat oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in percentage of body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Impact of the program
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life screening score (change from baseline)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Depression screening score (change from baseline)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HIV symptom screening score (change from baseline)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Genotoxic potential of faecal extracts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects with Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects with clinically significant neurological examination abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Subjects with laboratory test abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient State Index (PSI-)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propofol doses administered with Target Controlled Infusion (TCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Burst Suppression (in % of time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spectral Edge Frequency (SEF 95 in uV2/Hz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labor progression prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: 12 month youth quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 18 month youth quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 12 month youth functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 18 month youth functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Difference in Detection of Clinically Significant Arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical Assessment change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wechsler Preschool and Primary Scale of Intelligence (WPPSI-IV)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Completion of all preoperative and operative therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient reported main complaint
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: WBCs adhesion ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Successful Separation of Capsule and String
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Complete Viewing of Esophagus and Stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: duration of antibiotic treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Specific biomarkers assessed at 3 months after MTBI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific biomarkers assessed at 6 months after MTBI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of total eye score (NOSPECS severity score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chalder Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Psychomotor physical computerized test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell composition of the intracoronary thrombus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Oocytes Retrieved Per Patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of Mature Oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of Fertilized Oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of Frozen Embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of Total Dose-limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Have Died Due to Any Cause
Endpoint domain: Mortality/survival
Primary endpoint: frequency of partial tandem duplication of ALL1 (MLL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence or absence of vertebral fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in cerebral perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes